Navigation Links
Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
Date:2/14/2008

'Countless Patients Cannot Afford Life-Saving Biopharmaceuticals'

WASHINGTON, Feb. 14 /PRNewswire-USNewswire/ -- As part of its campaign to enact meaningful biogenerics legislation that would create a pathway for FDA approval of safe and effective biogenerics, CCPM unveiled a new print advertisement that features a footprint in the snow stating: "Don't Leave Patients Out in the Cold."

The ad highlights how meaningful biogenerics legislation should be balanced to foster innovation without excessive and unprecedented market exclusivity that simply extends brand monopolies. Such legislation would be an empty promise for patients.

In addition, CCPM released letters to the Administration and to the House Energy & Commerce Committee Leadership stressing the need for biologics legislation that provides a meaningful FDA pathway and not a pathway in name only.

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit http://www.competitiverx.com for more information and a list of CCPM members.

Contact: Katie Braden Huffard, 202-255-5216;

Andrea Hofelich, 703-647-2495; Charles Cote, 202-207-3605


'/>"/>
SOURCE CCPM
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
2. Agendia Joins the Personalized Medicine Coalition (PMC)
3. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
4. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
5. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
6. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
7. Technology Transforms Market Research in Pharmaceutical Industry
8. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
9. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
10. Vion Pharmaceuticals Holds Special Meeting of Stockholders
11. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is ... the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there ... therapeutic antibodies. , To meet this demand, the team at SCIEX has ...
(Date:3/22/2017)... ... March 21, 2017 , ... Aqua Design Innovations ... goal and raising over $30,000 in the first 40 minutes of crowdfunding. EcoQube ... herbs fast, easy, and affordably, anywhere. , “Simply add fertilized water and in ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered by ... high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration (VF) ...
(Date:3/22/2017)... WI (PRWEB) , ... March 22, 2017 , ... The ... scientific research agencies as outlined in the Administration’s recently published fiscal year 2018 budget ... the National Institutes of Health (NIH) by $5.8 billion or roughly 20% of its ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
Breaking Biology News(10 mins):